Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer，
网页链接。
Merus双抗，HER2/HER3，胰腺癌。突破性疗法资格认定。$Merus(MRUS)$
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
Zenocutuzumab (Zeno) granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration for the treatment of NRG1+ pancreatic cancer，
网页链接。
Merus双抗，HER2/HER3，胰腺癌。突破性疗法资格认定。$Merus(MRUS)$